@article{ref1,
title="Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders",
journal="Journal of clinical psychiatry",
year="2008",
author="McDougle, Christopher J. and Stigler, Kimberly A. and Erickson, Craig A. and Posey, David J.",
volume="69",
number="Suppl 4",
pages="15-20",
abstract="Atypical antipsychotics are emerging as the first-line pharmacologic treatment for irritability (i.e., aggression, self-injurious behavior, and severe tantrums) in children and adolescents with autistic and other pervasive developmental disorders. Results from placebo-controlled and open-label studies of clozapine, risperidone, olanzapine, quetiapine, ziprasidone, and aripiprazole in this subject population are reviewed. Additional placebo-controlled trials and studies of longer-term safety and tolerability are needed.<p /><p>Language: en</p>",
language="en",
issn="0160-6689",
doi="",
url="http://dx.doi.org/"
}